OXURION (EBR:OXUR) | WebDisclosure

PRESS RELEASE

published on 05/20/2025 at 18:00, 11 days 14 hours ago

Oxurion ontvangt transparantiekennisgevingen van Atlas Special Opportunities II LLC
Oxurion NV receives transparency notifications regarding shareholding percentages falling below thresholds. Atlas Special Opportunities II LLC sold voting securities affecting percentages. Visit www.oxurion.com for more info

Belgium Oxurion NV Transparency Notifications Shareholding Percentages Biofarmaceutical Company
PRESS RELEASE

published on 05/20/2025 at 18:00, 11 days 14 hours ago

Oxurion Receives Transparency Notifications from Atlas Special Opportunities II LLC
Oxurion NV received transparency notifications from Atlas Special Opportunities II, LLC regarding changes in share ownership per Belgian Transparency legislation. Oxurion is a biopharmaceutical company developing ophthalmic therapies

Biopharmaceutical Share Ownership Ophthalmic Therapies Oxurion NV Transparency Notifications
BRIEF

published on 05/16/2025 at 08:35, 16 days ago

Oxurion to Acquire Majority Stake in Axiodis CRO

Acquisition Revenue Growth Oxurion Axiodis CRO Clinical Biometrics
BRIEF

published on 05/16/2025 at 08:35, 16 days ago

Oxurion va acquérir une participation majoritaire dans Axiodis CRO

Acquisition Croissance Des Revenus Oxurion Axiodis CRO Biométrie Clinique
PRESS RELEASE

published on 05/16/2025 at 08:30, 16 days ago

Oxurion annonce la signature de l'accord ferme d'acquisition du français Axiodis CRO, spécialiste français de la biométrie
Oxurion NV acquiert 72% d'Axiodis CRO, une CRO spécialisée en biométrie clinique. Axiodis CRO prévoit un CA de 970K€ en 2025 et vise 2M€ en 2027

Chiffre D'affaires Acquisition Oxurion NV Axiodis CRO Biométrie Clinique
PRESS RELEASE

published on 05/16/2025 at 08:30, 16 days ago

Oxurion announces the signing of a binding agreement to acquire French biometrics specialist Axiodis CRO
Oxurion NV to acquire 72% of Axiodis CRO shares for €468,000, valuing the company at €650,000. Deal expected to close by June 2025. Axiodis CRO specializes in clinical biometrics, offers integrated services for clinical trials, and aims for revenue growth

Acquisition Revenue Growth Oxurion NV Axiodis CRO Clinical Biometrics
PRESS RELEASE

published on 05/16/2025 at 08:30, 16 days ago

Oxurion kondigt de ondertekening aan van een bindende overeenkomst tot overname van de Franse biometriespecialist Axiodis CRO
Oxurion NV erwirbt 72% des Aktienkapitals von Axiodis CRO für 468.000 EUR, um das Unternehmen auf 650.000 EUR zu bewerten. Transaktionsschluss erwartet bis Ende Juni 2025

Übernahme Transaktion Oxurion NV Axiodis CRO Aktienkapital
BRIEF

published on 05/15/2025 at 18:05, 16 days 14 hours ago

Oxurion reçoit des notifications de transparence d'Atlas Special Opportunities II LLC

Acquisition Actions Transparence Atlas Special Opportunities Oxurion
BRIEF

published on 05/15/2025 at 18:05, 16 days 14 hours ago

Oxurion Receives Transparency Notifications from Atlas Special Opportunities II LLC

Acquisition Actions Transparency Atlas Special Opportunities Oxurion
PRESS RELEASE

published on 05/15/2025 at 18:00, 16 days 14 hours ago

Oxurion ontvangt transparantiekennisgevingen van Atlas Special Opportunities II LLC
Oxurion NV announces receipt of transparency notifications regarding changes in shareholding percentages to comply with Belgian transparency legislation. Details in attached PDF file

Shareholding Oxurion NV Belgian Legislation Transparency Notifications PDF File

Published on 05/31/2025 at 06:16, 1 day 2 hours ago

Moderna Receives U.S. FDA Approval for COVID-19 Vaccine mNEXSPIKE
Published on 05/31/2025 at 03:30, 1 day 5 hours ago

Avant Brands Inc. Announces Voting Results From 2025 Annual General Meeting of Shareholders
Published on 05/31/2025 at 01:45, 1 day 7 hours ago

GLG Life Tech Corporation Reports 2025 First Quarter Financial Results
Published on 05/30/2025 at 23:10, 1 day 9 hours ago

CORRECTION: Nextech3D.ai Migrates MAP Dynamics to AWS, Enabling Scalable AI Architecture and Accelerated Deployment
Published on 05/30/2025 at 23:00, 1 day 9 hours ago

Battery X Metals Achieves Full Capacity Recovery on a Real-World Imbalanced Battery from the #2 Out-of-Warranty Electric Vehicle Model in the United States in Preliminary Trial

View all ACCESSWIRE

Published on 05/31/2025 at 21:00, 11 hours 55 minutes ago

Leclanché annonce le dépôt d'une demande de prolongation du délai de publication du rapport annuel 2024 et la suspension temporaire de la cotation de ses actions nominatives à la SIX Swiss Exchange
Published on 05/31/2025 at 21:00, 11 hours 55 minutes ago

Leclanché SA: Leclanché announces filing of request to extend the publication deadline for the 2024 Annual Report and the temporary suspension of trading of its registered shares on SIX Swiss Exchange
Published on 05/31/2025 at 18:37, 14 hours 18 minutes ago

Meyer Burger files for insolvency for German subsidiaries
Published on 05/31/2025 at 14:50, 18 hours 4 minutes ago

Turkiye Garanti Bankasi A.S.: Brokerage Houses Warrants Redemption Prices
Published on 05/31/2025 at 14:46, 18 hours 9 minutes ago

Turkiye Garanti Bankasi A.S.: CMB Approval for Bond Issuance to Foreign Markets

View all EQS

Published on 05/30/2025 at 22:00, 1 day 10 hours ago

Information sur les comptes annuels
Published on 05/30/2025 at 22:00, 1 day 10 hours ago

Information on the Annual Financial Statements
Published on 05/30/2025 at 18:14, 1 day 14 hours ago

Emova Group - Rapport annuel de Durabilité 23/24
Published on 05/28/2025 at 23:00, 3 days 9 hours ago

Standstill Commitments to hold shares of the company
Published on 05/28/2025 at 23:00, 3 days 9 hours ago

Engagements collectifs de conservation de titres de la société

View all LES ECHOS COMFI WIRE

News